Learn More
  • Valli De Re
  • 2008
Pegylated interferon alpha (peginterferon alpha) plus ribavirin is the current mainstay of treatment for patients with chronic HCV infection. When peginterferon alpha plus ribavirin is administered for the standard duration, a sustained virological response is achieved in around 50% of patients infected with HCV genotype 1 and around 80% of patients(More)
Several lines of evidence indicate that an impairment of EBV-specific immune responses may contribute to the pathogenesis of Hodgkin's dis ease (HD). At present, however, it is not clear whether a defective immu nity to EBV is a characteristic restricted to EBV-associated HD cases or a more generalized phenomenon, part of the inherent immune deficiency of(More)
anti-CD20 monoclonal antibody with an α Treatment of mixed cryoglobulinemia resistant to interferon-(577 articles) Immunotherapy (3667 articles) Clinical Trials and Observations Articles on similar topics can be found in the following Blood collections Information about subscriptions and ASH membership may be found online at: articles must include the(More)
  • 1